Share Email Print
cover

Proceedings Paper

Scavenger receptor-targeted photodynamic therapy of J774 tumors in mice: tumor response and concomitant immunity
Author(s): Michael R. Hamblin; David A. O'Donnell; Misbah Huzaira; Touqir Zahra
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

J774 is a cell line derived from Balb/c mice that in vitro behaves as macrophages (including scavenger-receptor expression) and has been widely used to study macrophage cell biology. In vivo it produces histiocytic lymphoma tumors that are invasive and metastatic. We report here on the response of subcutaneous J774 tumors to photodynamic therapy with scavenger-receptor targeted chlorin(e6). Bovine serum albumin was covalently conjugated with chlorin(e6), maleylated and purified by acetone precipitation and both this and free chlorin(e6) were injected IV into mice at 2 mg/kg. When tumors were illuminated with 665 nm laser-light after 24 hours there was a highly significant response (tumor volume and growth rate) for the conjugate, but this led to a relatively small survival increase due to the highly metastatic nature of the tumor. The free chlorin(e6) gave very little tumor response. When light was delivered 3 hours after injection the response from the conjugate disappeared due to insufficient time for the tumor cells to take up the photosensitizer by receptor-mediated endocytosis. Free chlorin(e6) at 3 hours, however, produced a total regression of the tumors due to a primarily vascular effect, but the mice died sooner than control animals. When J774 tumors were surgically removed at different times after implantation the mouse survival was proportional to the length of time they had had the tumor. We interpret this data to show that mice with J774 tumors slowly develop concomitant immunity and a PDT regimen that swiftly ablates the tumor will give worse survival results than a regimen with a slower tumor response.

Paper Details

Date Published: 27 June 2002
PDF: 10 pages
Proc. SPIE 4617, Laser Tissue Interaction XIII: Photochemical, Photothermal, and Photomechanical, (27 June 2002); doi: 10.1117/12.472513
Show Author Affiliations
Michael R. Hamblin, Massachusetts General Hospital/Harvard Medical School (United States)
David A. O'Donnell, Massachusetts General Hospital/Harvard Medical School (United States)
Misbah Huzaira, Massachusetts General Hospital/Harvard Medical School (United States)
Touqir Zahra, Massachusetts General Hospital/Harvard Medical School (United States)


Published in SPIE Proceedings Vol. 4617:
Laser Tissue Interaction XIII: Photochemical, Photothermal, and Photomechanical
Steven L. Jacques; Donald Dean Duncan; Sean J. Kirkpatrick; Andres Kriete; Donald Dean Duncan; Sean J. Kirkpatrick; Andres Kriete, Editor(s)

© SPIE. Terms of Use
Back to Top